Fig. 4From: Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysisa Sensitivity meta-analysis: stroke outcome by warfarin use, excluding studies with prevalent warfarin users. b Sensitivity meta-analysis: bleeding outcome by warfarin use, excluding studies with prevalent warfarin users. c Sensitivity meta-analysis: mortality by warfarin use, excluding studies with prevalent warfarin usersBack to article page